The therapeutic effect of FTY720 on lupus nephritis in autoimmune MRL/lpr mice

被引：0

作者：

Sugahara, K ^{[1
]}

Kataoka, H ^{[1
]}

Ohtsuki, M ^{[1
]}

Hoshino, Y ^{[1
]}

Chiba, K ^{[1
]}

机构：

[1] Mitsubishi Pharma Corp, Res Lab 3, Pharmaceut Res Unit, Div Res & Dev, Yokohama, Kanagawa, Japan

来源：

IMMUNOLOGY 2004: AUTOIMMUNITY, GENETIC AND DEGENERATIVE DISORDERS, MALIGNANCIES, AND TRANSPLANTATION | 2004年

关键词：

D O I：

暂无

中图分类号：

Q3 [遗传学];

学科分类号：

071007 ; 090102 ;

摘要：

Sphingosine 1-phosphate receptor agonist, FTY720 at oral doses of 0.03 to 1 mg/kg exhibited the prophylactic and therapeutic effect on lupus nephritis spontaneously developed in MRL/lpr mice. The therapeutical administration of FTY720 resulted in a decrease in the number of T cells, especially CD4(+) T cells, infiltrated into kidney as well as reduction of lymphocytes in blood. Moreover, the elevation of Th1 cytokine/chemokine mRNA expression was decreased in kidneys of FTY720-treated group. These results suggest that FTY720 decreases autoreactive Th1 cell infiltration into kidneys by reduction of circulating lymphocytes in blood, and thereby shows a marked therapeutic effect on progressing lupus nephritis of MRL/lpr mice.

引用

页码：271 / 274

页数：4

共 50 条

[1] Effects of FTY720 in MRL-lpr/lpr mice: Therapeutic potential in systemic lupus erythematosus
Okazaki, H
Hirata, D
Kamimura, T
Sato, H
Iwamoto, M
Yoshio, T
Masuyama, J
Fujimura, A
Kobayashi, E
Kano, S
Minota, S
[J]. JOURNAL OF RHEUMATOLOGY, 2002, 29 (04) : 707 - 716
[2] The therapeutic effect of FTY720 on experimental autoimmune encephalomyelitis in mice
Kataoka, H
Sugahara, K
Tanaka, H
Ohtsuki, M
Maeda, Y
Murata, M
Shimano, K
Chiba, K
[J]. IMMUNOLOGY 2004: AUTOIMMUNITY, GENETIC AND DEGENERATIVE DISORDERS, MALIGNANCIES, AND TRANSPLANTATION, 2004, : 87 - 89
[3] The in vivo induction of lymphocyte apoptosis in MRL-lpr/lpr mice treated with FTY720
Suzuki, S
Li, XK
Shinomiya, T
Enosawa, S
Amemiya, H
Amari, M
Naoe, S
[J]. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1997, 107 (01): : 103 - 111
[4] Therapeutic effects of C2-Ceramide and FTY720 on the clinical course of MRL-lpr/lpr mice.
Okazaki, H
Hirata, D
Kamimura, T
Sato, H
Kano, S
Minota, S
[J]. ARTHRITIS AND RHEUMATISM, 1998, 41 (09): : S175 - S175
[5] EFFECT OF MACROPHAGE ACTIVATION ON LUPUS NEPHRITIS IN MRL/MPJ-LPR/LPR(MRL/L)MICE
IZUMINO, K
FUTAMURA, A
NAKAGAWA, Y
ENTANI, C
TAKATA, M
INOUE, H
IIDA, H
[J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1995, 6 (03): : 870 - 870
[6] Amelioration of autoimmune nephritis by imatinib in MRL/lpr mice
Sadanaga, A
Nakashima, H
Masutani, K
Miyake, K
Shimizu, S
Igawa, T
Sugiyama, N
Niiro, H
Hirakata, H
Harada, M
[J]. ARTHRITIS AND RHEUMATISM, 2005, 52 (12): : 3987 - 3996
[7] Prevention of autoimmune diabetes by FTY720 in nonobese diabetic mice
Maki, T
Gottschalk, R
Monaco, AP
[J]. TRANSPLANTATION, 2002, 74 (12) : 1684 - 1686
[8] Inhibitory oligodeoxynucleotide inhibits the progression of autoimmune nephritis in the lupus prone MRL-lpr/lpr mice.
Hoshi, N
Watanabe, H
Kobayashi, H
Sato, Y
[J]. ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S627 - S628
[9] Evaluation of Experimental Autoimmune Uveitis in Mice Treated with FTY720
Commodaro, Alessandra Goncalves
Peron, Jean Pierre S.
Lopes, Camila Takao
Arslanian, Christina
Belfort, Rubens, Jr.
Rizzo, Luiz Vicente
Bueno, Valquiria
[J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (05) : 2568 - 2574
[10] ALW peptide ameliorates lupus nephritis in MRL/lpr mice
Huixia Wang
Mei Lu
Siyue Zhai
Kunyi Wu
Lingling Peng
Jie Yang
Yumin Xia
[J]. Arthritis Research & Therapy, 21

← 1 2 3 4 5 →